LU Shun, YU Yong-feng, ZHANG Yi-chen. Nivolumab Versus Docetaxel in Advanced Squamous-Cell Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2015, 15(4): 225-227. DOI: 10.3969/j.issn.1671-5144.2015.04.010
|
Citation:
|
LU Shun, YU Yong-feng, ZHANG Yi-chen. Nivolumab Versus Docetaxel in Advanced Squamous-Cell Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2015, 15(4): 225-227. DOI: 10.3969/j.issn.1671-5144.2015.04.010
|
LU Shun, YU Yong-feng, ZHANG Yi-chen. Nivolumab Versus Docetaxel in Advanced Squamous-Cell Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2015, 15(4): 225-227. DOI: 10.3969/j.issn.1671-5144.2015.04.010
|
Citation:
|
LU Shun, YU Yong-feng, ZHANG Yi-chen. Nivolumab Versus Docetaxel in Advanced Squamous-Cell Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2015, 15(4): 225-227. DOI: 10.3969/j.issn.1671-5144.2015.04.010
|
DownLoad: